Your browser doesn't support javascript.
loading
Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma.
Fontebasso, Adam M; Papillon-Cavanagh, Simon; Schwartzentruber, Jeremy; Nikbakht, Hamid; Gerges, Noha; Fiset, Pierre-Olivier; Bechet, Denise; Faury, Damien; De Jay, Nicolas; Ramkissoon, Lori A; Corcoran, Aoife; Jones, David T W; Sturm, Dominik; Johann, Pascal; Tomita, Tadanori; Goldman, Stewart; Nagib, Mahmoud; Bendel, Anne; Goumnerova, Liliana; Bowers, Daniel C; Leonard, Jeffrey R; Rubin, Joshua B; Alden, Tord; Browd, Samuel; Geyer, J Russell; Leary, Sarah; Jallo, George; Cohen, Kenneth; Gupta, Nalin; Prados, Michael D; Carret, Anne-Sophie; Ellezam, Benjamin; Crevier, Louis; Klekner, Almos; Bognar, Laszlo; Hauser, Peter; Garami, Miklos; Myseros, John; Dong, Zhifeng; Siegel, Peter M; Malkin, Hayley; Ligon, Azra H; Albrecht, Steffen; Pfister, Stefan M; Ligon, Keith L; Majewski, Jacek; Jabado, Nada; Kieran, Mark W.
Afiliación
  • Fontebasso AM; 1] Division of Experimental Medicine, Montreal Children's Hospital, McGill University and McGill University Health Centre, Montreal, Quebec, Canada. [2].
  • Papillon-Cavanagh S; 1] Department of Human Genetics, McGill University, Montreal, Quebec, Canada. [2].
  • Schwartzentruber J; 1] Wellcome Trust Sanger Institute, Hinxton, UK. [2].
  • Nikbakht H; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
  • Gerges N; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
  • Fiset PO; Department of Pathology, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada.
  • Bechet D; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
  • Faury D; 1] Department of Human Genetics, McGill University, Montreal, Quebec, Canada. [2] Department of Pediatrics, McGill University, Montreal, Quebec, Canada.
  • De Jay N; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
  • Ramkissoon LA; Department of Medical Oncology, Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Corcoran A; Department of Medical Oncology, Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Jones DT; Division of Pediatric Neuro-oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Sturm D; Division of Pediatric Neuro-oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Johann P; Division of Pediatric Neuro-oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Tomita T; Department of Neurological Surgery, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University, Chicago, Illinois, USA.
  • Goldman S; Department of Pediatrics Hematology-Oncology, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University, Chicago, Illinois, USA.
  • Nagib M; Clinical Pediatric Neurosurgical Oncology, Department of Surgery, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Bendel A; Department of Pediatric Hematology-Oncology, Children's Hospitals and Clinics of Minnesota, Minneapolis, Minnesota, USA.
  • Goumnerova L; 1] Department of Neurosurgery, Boston Children's Hospital, Boston, Massachusetts, USA. [2] Harvard Medical School, Boston, Massachusetts, USA.
  • Bowers DC; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Leonard JR; Department of Neurological Surgery, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
  • Rubin JB; Department of Pediatrics, Hematology-Oncology, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
  • Alden T; Department of Neurological Surgery, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University, Chicago, Illinois, USA.
  • Browd S; Department of Neurosurgery, Seattle Children's Hospital, Seattle, Washington, USA.
  • Geyer JR; Cancer and Blood Disorders Center, Seattle Children's Hospital, Seattle, Washington, USA.
  • Leary S; Cancer and Blood Disorders Center, Seattle Children's Hospital, Seattle, Washington, USA.
  • Jallo G; Department of Neurological Surgery, Johns Hopkins Hospital, Baltimore, Maryland, USA.
  • Cohen K; Department of Pediatric Hematology-Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA.
  • Gupta N; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.
  • Prados MD; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.
  • Carret AS; Department of Hematology-Oncology, Centre Hospitalier Universitaire (CHU) Sainte-Justine, Université de Montréal, Montreal, Quebec, Canada.
  • Ellezam B; Department of Pathology, Centre Hospitalier Universitaire (CHU) Sainte-Justine, Université de Montréal, Montreal, Quebec, Canada.
  • Crevier L; Department of Neurosurgery, Centre Hospitalier Universitaire (CHU) Sainte-Justine, Université de Montréal, Montreal, Quebec, Canada.
  • Klekner A; Department of Neurosurgery, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary.
  • Bognar L; Department of Neurosurgery, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary.
  • Hauser P; 2nd Department of Paediatrics, Semmelweis University, Budapest, Hungary.
  • Garami M; 2nd Department of Paediatrics, Semmelweis University, Budapest, Hungary.
  • Myseros J; Department of Neurosurgery, Children's National Medical Center, Washington, DC, USA.
  • Dong Z; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada.
  • Siegel PM; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada.
  • Malkin H; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Ligon AH; 1] Department of Medical Oncology, Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Harvard Medical School, Boston, Massachusetts, USA. [3] Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Albrecht S; Department of Pathology, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada.
  • Pfister SM; Division of Pediatric Neuro-oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Ligon KL; 1] Department of Medical Oncology, Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Harvard Medical School, Boston, Massachusetts, USA. [3] Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA. [4] Department of Path
  • Majewski J; 1] Department of Human Genetics, McGill University, Montreal, Quebec, Canada. [2].
  • Jabado N; 1] Division of Experimental Medicine, Montreal Children's Hospital, McGill University and McGill University Health Centre, Montreal, Quebec, Canada. [2] Department of Human Genetics, McGill University, Montreal, Quebec, Canada. [3] Department of Pediatrics, McGill University, Montreal, Quebec, Canad
  • Kieran MW; 1] Harvard Medical School, Boston, Massachusetts, USA. [2] Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [3] Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA. [4].
Nat Genet ; 46(5): 462-6, 2014 May.
Article en En | MEDLINE | ID: mdl-24705250
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Astrocitoma / Neoplasias Encefálicas / Regulación Neoplásica de la Expresión Génica / Genoma Humano / Receptores de Activinas Tipo I / Mutación Límite: Animals / Child / Humans Idioma: En Revista: Nat Genet Asunto de la revista: GENETICA MEDICA Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Astrocitoma / Neoplasias Encefálicas / Regulación Neoplásica de la Expresión Génica / Genoma Humano / Receptores de Activinas Tipo I / Mutación Límite: Animals / Child / Humans Idioma: En Revista: Nat Genet Asunto de la revista: GENETICA MEDICA Año: 2014 Tipo del documento: Article